Drug intelligence / Profile preview

isoconazole nitrate + diflucortolone valerate

Development stage
Unknown
Lead developer
Bayer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Isoconazole nitrate + diflucortolone valerate is a fixed-dose combination topical medication used primarily for the initial or interim treatment of superficial fungal skin infections that are accompanied by highly inflammatory or eczematous skin conditions. Isoconazole nitrate is a broad-spectrum imidazole antifungal that acts by inhibiting ergosterol synthesis in fungal cell membranes, leading to cell death. It also exhibits antibacterial activity against some gram-positive bacteria. Diflucortolone valerate is a potent synthetic corticosteroid that reduces inflammation, pruritus, and allergic reactions in the skin by suppressing the inflammatory response and various mediators. The combination is particularly indicated where both rapid reduction of inflammation and reliable antifungal action are required, such as in tinea and other dermatomycoses affecting areas like the hands, feet (interdigital spaces), inguinal and genital regions. The product is typically formulated as a cream, with recommended short-term use to avoid complications of topical corticosteroid therapy[1][2][3][4][5][7][10].

Brand names
TravocortDuoskin
Other names
isoconazole nitrate + diflucortolone valerate
02

Targets

GR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on isoconazole nitrate + diflucortolone valerate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isoconazole nitrate + diflucortolone valerate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call